Sarcoma  >>  Hensify (crystalline hafnium oxide)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hensify (crystalline hafnium oxide) / Nanobiotix, J&J
Act.In.Sarc, NCT02379845: NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk Wall

Completed
2/3
180
Europe, RoW
NBTXR3, PEP503, Radiation therapy
Nanobiotix, PharmaEngine
Adult Soft Tissue Sarcoma
05/18
09/20

Download Options